Publications Archive - KalVista Pharmaceuticals

Presentations & Publications

We are committed to rigorous science and innovative drug development, and we are excited to share our ongoing progress.

Apply Reset

Topic

Forum

Year

Apply Reset

Showing 2 out of 2

Plasma kallikrein mediates brain hemorrhage and edema caused by tissue plasminogen activator therapy in mice after stroke.

Simao F, Ustunkaya T, Clermont AC, and Feener EP.
Blood. 2017.
PMID:28130211

Intraocular hemorrhage causes retinal vascular dysfunction via plasma kallikrein.

Liu J, Clermont AC, Gao BB, Feener EP.
Invest Ophthalmol Vis Sci. 2013;54:1086-1094.
PMID:23299478

About